There are a variety of wound healing drugs and treatments in clinical trials. At the present time without them, this is interesting, but I don't see the application. A patient that is going to have severe mucocitis (I did, morphine level pain) isn't going to stop treatments that might save their lives in order to avoid mucocitis sores. They are going to tough it out, because the alternative is that the cancer will continue to gain ground if they do not. This is only relevant as a technology when there is something that is available that will counteract the development of mucocitis or reduce its impact. Knowing who is going to have the worst cases of it does not help right now.

Brian, stage 4 oral cancer survivor. OCF Founder and Director. The first responsibility of a leader is to define reality. The last is to say thank you. In between, the leader is a servant.